Exploratory clinical trials evaluating the usefulness of fecal calprotectin as a monitoring of Crohn's disease using MR enterography
Not Applicable
- Conditions
- Crohn's disease
- Registration Number
- JPRN-UMIN000034576
- Lead Sponsor
- Juntendo University Nerima Hospital Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who can not obtain written informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fecal Calprotectin values
- Secondary Outcome Measures
Name Time Method Fecal Calprotectin values, Crohn's disease clinical activity Index score, blood test every 2 months Small bowel lesions with MRE at start